We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
(-3.6%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62M |
| 2 |
Amazon
AMZN
|
+$53.3M |
| 3 |
CVS Health
CVS
|
+$40.3M |
| 4 |
PayPal
PYPL
|
+$34.8M |
| 5 |
McDonald's
MCD
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$43.4M |
| 3 |
Charter Communications
CHTR
|
+$42.4M |
| 4 |
Comcast
CMCSA
|
+$40.3M |
| 5 |
Mastercard
MA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.54% |
| 2 | Technology | 11.9% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Healthcare | 8.91% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Turkcell
TKC
$4.79B
| $60.4K | ﹤0.01% |
12,602
+592
| +5% | +$2.32K |
|
3877
Xylem
XYL
$28.3B
| $60.1K | ﹤0.01% |
544
-103,481
| -99% | -$10.8M |
|
|
TUYA
3878
Tuya Inc
TUYA
$1.13B
| $59K | ﹤0.01% |
30,915
-41,400
| -57% | -$50.3K |
|
3879
Mitek Systems
MITK
$837M
| $58.7K | ﹤0.01% |
6,059
-65,654
| -92% | -$691K |
|
|
BRMK
3880
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $57.8K | ﹤0.01% |
16,244
-97,620
| -86% | -$454K |
|
|
APN.WS
3881
DELISTED
Apeiron Capital Investment Corp. Redeemable Warrants
APN.WS
| $57.6K | ﹤0.01% |
384,100
| – | – |
|
3882
Kura Oncology
KURA
$874M
| $57.1K | ﹤0.01% |
4,600
-301,437
| -98% | -$4.38M |
|
3883
Purple Innovation
PRPL
$39.6M
| $57K | ﹤0.01% |
476
-1,022
| -68% | -$112K |
|
3884
Personalis
PSNL
$1.55B
| $56.8K | ﹤0.01% |
28,674
-6,385
| -18% | -$16.1K |
|
3885
Fortuna Silver Mines
FSM
$3.18B
| $56.7K | ﹤0.01% |
15,126
-38,533
| -72% | -$127K |
|
3886
STAG Industrial
STAG
$7.09B
| $56.5K | ﹤0.01% |
1,749
-8,352
| -83% | -$262K |
|
3887
DuPont de Nemours
DD
$19.1B
| $55.9K | ﹤0.01% |
649
-256,670
| -100% | -$20.5M |
|
|
TGB
3888
Trekor Metals
TGB
$3.21B
| $55.9K | ﹤0.01% |
+38,046
| New | +$48K |
|
3889
StealthGas
GASS
$328M
| $55.7K | ﹤0.01% |
+20,775
| New | +$62.2K |
|
3890
ACV Auctions
ACVA
$1.27B
| $54.8K | ﹤0.01% |
6,670
-8,886
| -57% | -$74.2K |
|
3891
Bruker
BRKR
$8.58B
| $53.7K | ﹤0.01% |
786
-11,758
| -94% | -$747K |
|
3892
Archrock
AROC
$5.81B
| $53.5K | ﹤0.01% |
+5,954
| New | +$47.7K |
|
3893
Nano X Imaging
NNOX
$73.8M
| $53.4K | ﹤0.01% |
+7,233
| New | +$80.1K |
|
3894
Precigen
PGEN
$2.51B
| $53.4K | ﹤0.01% |
+35,101
| New | +$60.4K |
|
|
AMPS
3895
DELISTED
Altus Power
AMPS
| $52.9K | ﹤0.01% |
+8,121
| New | +$66.3K |
|
3896
BridgeBio Pharma
BBIO
$16.6B
| $52.8K | ﹤0.01% |
6,925
-452,011
| -98% | -$4.33M |
|
3897
Enliven Therapeutics
ELVN
$4.35B
| $52.4K | ﹤0.01% |
+3,200
| New | +$51.1K |
|
|
OSG
3898
DELISTED
Overseas Shipholding Group Inc.
OSG
| $52.3K | ﹤0.01% |
+18,103
| New | +$52.5K |
|
|
FXLV
3899
DELISTED
F45 Training Holdings Inc.
FXLV
| $51.9K | ﹤0.01% |
+18,226
| New | +$55.3K |
|
3900
Compass Therapeutics
CMPX
$400M
| $51.8K | ﹤0.01% |
+10,300
| New | +$41.1K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.
- Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
- Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
- Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
- Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
- Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
- Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.